Guest Authors

Guest Authors
The Revolving Door is the place where we publish occasional articles by guest writers. If you would like to submit an article for publication, please contact editor Bob Leahy at This email address is being protected from spambots. You need JavaScript enabled to view it.

It’s time to stop linking ‘loose morals’ to immigrants with HIV

published: February, 05, 2018 Written by // Guest Authors - Revolving Door Categories // African, Caribbean and Black, Activism, Social Media, Current Affairs, Women, Legal, Revolving Door, Living with HIV, Media, Guest Authors, Opinion Pieces

From The Conversation, guest author Laura Bisaillon on rampant HIV discrimination through the immigration process.

It’s time to stop linking ‘loose morals’ to immigrants with HIV

Are you kidding me? With nearly four decades under our collective belts of global experience working on HIV and AIDS, we are past considering it acceptable to link someone’s health status with their perceived sexual “moral values.” Such were my thoughts after reading and reflecting on an article in The Toronto Star this month: “Decision-maker slammed as ‘Moral Police’ for refusing immigration to HIV-positive man.” I have researched medical inadmissibility decision-making and

Taking multiple Rx drugs raises risks for aging adults with and without HIV

published: February, 02, 2018 Written by // Guest Authors - Revolving Door Categories // Social Media, Gay Men, Research, Health, International , Revolving Door, Living with HIV, Guest Authors, Media

From Yale News, Ziba Kashef reports on a Yale-led study examining the effects of polypharmacy on people living with or without HIV.

Taking multiple Rx drugs raises risks for aging adults with and without HIV

(© stock.adobe.com) Taking five or more prescription medications increases the risk of hospitalization and death in older adults infected with HIV and comparable adults without HIV. The findings of this Yale-led study highlight the potential risks of prescribing additional drugs to patients with multiple medical conditions. The research was published online in the journal AIDS. The use of multiple medications is known as polypharmacy, a common concern due to clearly established increased

An epidemic of bullshit

published: February, 01, 2018 Written by // Guest Authors - Revolving Door Categories // Social Media, As Prevention , Gay Men, Current Affairs, Treatment Guidelines -including when to start, Health, International , Revolving Door, Treatment, Guest Authors, Media

From Overland, guest author Daniel Reeders: "... messages on sexual health almost invariably focus on sex rather than health."

An epidemic of bullshit

Image credit: Reginald Mount, ‘The easy girlfriend’ (poster), Norwich: Her Majesty’s Stationery Office, 1943-44. This file comes from Wellcome Images, a website operated by Wellcome Trust, a global charitable foundation based in the United Kingdom. Refer to Wellcome blog post (archive). This article by Daniel Reeders previously appeared at Overland, here. Two or three times a year, there’ll be a major conference on sexual health, or a report released on how many new sexually tr

4 out of 5 gay, bi and men who have sex with men are aware of HIV prevention drug, PrEP

published: February, 01, 2018 Written by // Guest Authors - Revolving Door Categories // Social Media, African, Caribbean and Black, As Prevention , Gay Men, Current Affairs, Treatment Guidelines -including when to start, Research, Health, Sexual Health, Revolving Door, Treatment, Guest Authors, Media

Indigenous, Latino, bisexual and single men less likely to be aware of newly publicly-funded HIV prevention medication

4 out of 5 gay, bi and men who have sex with men are aware of HIV prevention drug, PrEP

(Vancouver, January 31, 2018) A new study shows most of gay, bi, men who have sex with men (MSM) and other MSM, are aware of PrEP (pre-exposure prophylaxis) - an HIV prevention drug recently made available at no charge to British Columbians at risk of HIV - according to the Momentum Health Study at the BC Centre for Excellence in HIV/AIDS. “Gay, bisexual, MSM and other MSM in Canada accounted for 56.8% of all new cases of HIV in Canada,” says research scientist, Nathan Lachowsky. “Incre

600 people a week turned away from oversubscribed sexual health clinics at one London NHS trust

published: January, 31, 2018 Written by // Guest Authors - Revolving Door Categories // Social Media, African, Caribbean and Black, As Prevention , Gay Men, Current Affairs, Newly Diagnosed, Treatment Guidelines -including when to start, Women, Health, International , Sexual Health, Revolving Door, Treatment, Guest Authors, Media

Closures have taken place across central London and remaining clinics across the capital are facing unmanageable demands. From the Evening Standard, Eleanor Rose reports.

600 people a week turned away from oversubscribed sexual health clinics at one London NHS trust

Testing: Digital services will allow people to carry out tests at home, but the rollout has been delayed. To read the complete story by Eleanor Rose, visit The Evening Standard, here. Up to 600 people per week are being turned away from oversubscribed sexual health clinics at one of London’s NHS trusts, an expert has warned. Dr Mark Lawton of the British Association of Sexual Health and HIV said the data showing hundreds of people are being turned away from clinic at Guy’s and St Tho

What will be the impact of PrEP in Ontario?

published: January, 30, 2018 Written by // Guest Authors - Revolving Door Categories // Social Media, As Prevention , Treatment Guidelines -including when to start, Research, Health, Treatment, Revolving Door, Guest Authors, Media

The breadth of data being collected is intended to help answer the wide range of questions about what “real-world” PrEP use looks like in the province. Jack Mohr of the Ontario PrEP Cohort Study has this report.

What will be the impact of PrEP in Ontario?

After years spent waiting, more widespread access to Pre-Exposure Prophylaxis (PrEP) in Ontario finally seems to be taking shape. Health Canada approval for generic forms of tenofovir disoproxil fumarate/emtricitabine (the drug combination used for PrEP) has drastically decreased out of pocket costs for PrEP.  This development, along with concerted lobbying from HIV activists, also led to the addition of PrEP to the Ontario Drug Benefit formulary in September 2017. While these changes don’t

Study links gut-homing protein levels with HIV infection risk, disease progression

published: January, 30, 2018 Written by // Guest Authors - Revolving Door Categories // Social Media, African, Caribbean and Black, As Prevention , Gay Men, Treatment Guidelines -including when to start, Women, Health, Research, International , Revolving Door, Treatment, Guest Authors, Media

From the National Institutes of Health: NIH clinical trial is testing antibody against the protein in people with HIV.

Study links gut-homing protein levels with HIV infection risk, disease progression

For the first time, scientists have shown a relationship between the proportion of key immune cells that display high levels of a gut-homing protein called alpha-4 beta-7 at the time of HIV infection and health outcomes. Previous research illustrated this relationship in monkeys infected with a simian form of HIV. The new study found that women who had more CD4+ T cells displaying high levels of alpha-4 beta-7 on their surface were more likely to become infected with HIV, and the virus damage

Women with HIV less likely to receive recommended treatments for gynaecologic cancers

published: January, 29, 2018 Written by // Guest Authors - Revolving Door Categories // Social Media, As Prevention , Treatment Guidelines -including when to start, Women, Health, International , Revolving Door, Treatment, Living with HIV, Guest Authors, Media

Toxicity and patient factors were the main reasons why women did not receive treatment recommended in guidelines.From AIDSmap, Michael Carter reports.

Women with HIV less likely to receive recommended treatments for gynaecologic cancers

The majority of HIV-positive women diagnosed with gynaecological cancer do not receive treatment recommended by cancer guidelines, according to research conducted in the United States and published in AIDS. Women whose care did not match guideline standards had poorer survival compared to women who received the recommended care. Toxicity and patient factors were the main reasons why women did not receive treatment recommended in guidelines. “To our knowledge, there is no case series de

Inclusion and respect – appreciating the role people living with HIV have with our research partners

published: January, 26, 2018 Written by // Guest Authors - Revolving Door Categories // Activism, Social Media, Current Affairs, Research, International , Revolving Door, Media, Guest Authors

Please sign this petition calling for GIPA to be acknowledged in HIV research findings

Inclusion and respect – appreciating the role people living with HIV have with our research partners

The partnerships forged between people living with HIV and researchers have been an essential foundation upon which the response to the HIV epidemic has grown and the time has come to reaffirm and recommit to principles of inclusion and respect in the conduct of presenting research findings that impacts on our lives. The early years of the HIV epidemic ushered in a radically different approach to traditional medical and clinical research. Academics and activists held a shared understanding th

Public forum: making all the tools better to prevent HIV

published: January, 25, 2018 Written by // Guest Authors - Revolving Door Categories // Social Media, Revolving Door, Media, Guest Authors

Hear an update of how Toronto can end HIV transmissions.

Public forum: making all the tools better to prevent HIV

Leading Toronto researchers and clinicians invite you to a discussion of how HIV prevention tools are improving and combine to get us to zero new infections. (Speakers: Sharmistha Mishra, Rupert Kaul, Malika Sharma, Beth Rachlis, Taylor Sicard, Isaac Bogoch, Abigail Kroch.  Moderator: R. Reinhard) When: Wednesday, February 7, 2018 6:30-8:30 PM Where: Hart House Music Room (U. of Toronto campus) Elevator and access ramp accessible. Light refreshments will be provided. Please RVSP by email

The term ‘LGBTI’ confuses desire, behaviour and identity – it’s time for a rethink

published: January, 25, 2018 Written by // Guest Authors - Revolving Door Categories // African, Caribbean and Black, Social Media, Gay Men, Current Affairs, International , Revolving Door, Media, Guest Authors, Opinion Pieces, Population Specific

From The Conversation, Dennis Altman: "Desire, behaviour and identity are distinct, and do not always overlap."

The term ‘LGBTI’ confuses desire, behaviour and identity – it’s time for a rethink

This article by Dennis Altman prevously appeared at The Conversation, here. The rise of sexually transmissible diseases made front-page news in The Age, which tried to make sense of the rise among “gay men” and “heterosexual people”. This illustrates the increasingly common confusion between behaviour and identity. What is involved is sexual contact, or to use the expression common in the early days of the AIDS epidemic, “the exchange of bodily fluids”. Whether people involve

Faster action on adherence is needed after viral load becomes detectable, researchers warn global treatment programmes

published: January, 24, 2018 Written by // Guest Authors - Revolving Door Categories // Social Media, African, Caribbean and Black, As Prevention , Treatment Guidelines -including when to start, Newly Diagnosed, Research, Health, International , Treatment, Revolving Door, Media, Guest Authors

“Our results show that any detectable viral load between 51 and 999 copies per ml leads to poorer treatment outcomes than successful virological suppression of less than 50 copies per ml,” write the investigators. From AIDSmap, Keith Alcorn reports.

Faster action on adherence is needed after viral load becomes detectable, researchers warn global treatment programmes

Low-level HIV viral load, above the limit of detection, is an important warning signal for future treatment failure and World Health Organization guidelines on spotting treatment failure need to be revised to encourage greater vigilance and swifter action by healthcare providers in lower- and middle-income settings, investigators report in The Lancet Infectious Diseases. The study, carried out by Annemarie Wensing and colleagues at the University of Utrecht in the Netherlands and University

The power of "no"

published: January, 22, 2018 Written by // Guest Authors - Revolving Door Categories // Social Media, Gay Men, Health, Legal, Lifestyle, Revolving Door, Media, Guest Authors, Opinion Pieces, Sex and Sexuality

From FS Magazine, Hadley Stewart: "Despite having consented to sex, we don’t necessarily make it clear what we’re consenting to. How able do you feel to negotiate in the bedroom?"

The power of

If, like me, you’ve never sat down and thought about the term ‘consent’, you’d be forgiven for thinking that it doesn’t really apply to you. Often we associate the term with the law, meaning that it’s easy to think it’s something that doesn’t form part of our lives unless we’ve been the victim of a crime. A sexual assault, for instance, is often paired up with the notion of consent. So does that mean we’ve never consented to anything or used our power of consent? Probably

Long-acting injectable ARVs are convenient and private, study participants report

published: January, 18, 2018 Written by // Guest Authors - Revolving Door Categories // Social Media, Gay Men, As Prevention , Treatment Guidelines -including when to start, Research, Health, International , Treatment, Revolving Door, Living with HIV, Guest Authors, Media

From NAM aidsmap, Roger Pebody reports on two studies, one using long-acting injectables as TasP and one using them as PrEP.

Long-acting injectable ARVs are convenient and private, study participants report

HIV-positive people who took injectable cabotegravir + rilpivirine every four or eight weeks as antiretroviral therapy found it more convenient and discreet than daily pills, also feeling that it eliminated a “daily reminder of living with HIV”, Deanna Kerrigan and colleagues report in PLOS One. Similarly, HIV-negative men who took injectable cabotegravir every 12 weeks as pre-exposure prophylaxis (PrEP) felt that it was probably more convenient and easier to adhere to than dai

Common birth control shot linked to risk of HIV infection

published: January, 17, 2018 Written by // Guest Authors - Revolving Door Categories // African, Caribbean and Black, Social Media, As Prevention , Treatment Guidelines -including when to start, Women, Research, Health, International , Treatment, Revolving Door, Media, Guest Authors

Research indicates alternative contraception methods may help protect women.

Common birth control shot linked to risk of HIV infection

Washington, DC - Transitioning away from a popular contraceptive shot known as DMPA could help protect women in Sub-Saharan Africa and other high-risk regions from becoming infected with HIV, according to a research review published in the Endocrine Society’s journal Endocrine Reviews. The predominant contraceptive in Sub-Saharan Africa is depot-medroxyprogesterone acetate (DMPA)—a birth control shot administered every three months. Human studies suggest DMPA use may raise the risk of H

<<  1 2 [34 5 6 7  >>